{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:56Z","timestamp":1772165696256,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Light and heavy chain deposition disease (LHCDD) is a rare condition characterised by the deposition of immunoglobulin components in the kidneys. Similarly, Amyloidosis is also caused by the deposition of light chain and\/or heavy chain components of immunoglobulins which are folded into amyloid fibrils characterised by Congophilic deposits that exhibit apple-green birefringence under polarised light. Only a handful of reports describing LHCDD with amyloid fibril deposition have been previously published, however, none have characterized the composition of the deposited immunoglobulin components via mass spectrometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report a case of a 79-year-old Japanese woman with nephrotic syndrome. Bone marrow aspiration revealed a slight proliferation of plasma cells (under 10%). Immunofluorescence assessment of renal biopsy showed amyloid-like deposits in the glomerulus that were positive for IgA and kappa. Further, the Congo red staining of the deposits was faintly positive, and only a slight birefringence was detected. Electron microscopy confirmed fine fibrillar structures and non-amyloid deposits. Finally, mass spectrometry revealed that the deposits were composed of abundant amounts of light chain with small amounts of heavy chain. Therefore, the patient was diagnosed with LHCDD and focal amyloid deposition. Chemotherapy was subsequently initiated, which resulted in haematological and renal response. Under polarised light, faint birefringence with Congo red staining and periodic acid-methenamine silver positivity indicated that the deposits were mostly non-amyloid fibrils with a small component of amyloid fibrils. Generally, the diagnosis of heavy- and light-chain amyloidosis is defined by greater heavy chain deposition compared to the light chain. However, in our case, contrary to the definition, the light-chain deposition was far greater than that of the heavy-chain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This is the first case of LHCDD with focal amyloid deposition diagnosed by analysing the glomerular deposits by mass spectrometry.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-023-03207-0","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T19:02:32Z","timestamp":1687806152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Light and heavy chain deposition disease with focal amyloid deposition diagnosed with mass spectrometry: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuki","family":"Shimamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagaaki","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Yazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuyuki","family":"Kametani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kasuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Sekijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Naiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Iwano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"3207_CR1","first-page":"545","volume":"42","author":"JL Preud\u2019Homme","year":"1980","unstructured":"Preud\u2019Homme JL, Morel-Maroger L, Brouet JC, Mihaesco E, Mery JP, Seligmann M. Synthesis of abnormal heavy and light chains in multiple myeloma with visceral deposition of monoclonal immunoglobulin. Clin Exp Immunol. 1980;42:545\u201353.","journal-title":"Clin Exp Immunol"},{"key":"3207_CR2","doi-asserted-by":"publisher","first-page":"970","DOI":"10.2169\/internalmedicine.44.970","volume":"44","author":"M Sakakima","year":"2005","unstructured":"Sakakima M, Fujigaki Y, Tsuji T, Fukasawa H, Miyaji T, Naito K, et al. High dose chemotherapy and stem cell support in a patient of light- and heavy-chain deposition disease with abnormal marrow cell surface antigens and no monoclonal protein. Intern Med. 2005;44:970\u20134.","journal-title":"Intern Med"},{"key":"3207_CR3","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/ndt\/13.6.1438","volume":"13","author":"JJ Montseny","year":"1998","unstructured":"Montseny JJ, Kleinknecht D, Meyrier A, Vanhille P, Simon P, Pruna A, et al. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Nephrol Dial Transplant. 1998;13:1438\u201345.","journal-title":"Nephrol Dial Transplant"},{"key":"3207_CR4","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2215\/CJN.07420619","volume":"15","author":"RF Dubin","year":"2020","unstructured":"Dubin RF, Rhee EP. Proteomics and metabolomics in kidney disease, including insights into etiology, treatment, and prevention. Clin J Am Soc Nephrol. 2020;15:404\u201311.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3207_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-018-1050-y","volume":"19","author":"S Manabe","year":"2018","unstructured":"Manabe S, Iwasaki C, Hatano M, Kametani F, Yazaki M, Nitta K, et al. AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; A case mimicking AHL amyloidosis. BMC Nephrol. 2018;19:1\u20136.","journal-title":"BMC Nephrol"},{"key":"3207_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000185616","volume":"52","author":"X Troussard","year":"1989","unstructured":"Troussard X, Hurault de Ligny B, Ganeval D, Mandard JC, Ryckelynck JP, et al. Massive systemic amyloidosis associated with light-chain deposition disease. Nephron. 1989;52:139\u201343. https:\/\/doi.org\/10.1159\/000185616.","journal-title":"Nephron"},{"key":"3207_CR7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10157-009-0221-3","volume":"13","author":"N Nakayama","year":"2009","unstructured":"Nakayama N, Fujigaki Y, Tsuji T, Sakakima M, Yasuda H, Togawa A, et al. Rapid deterioration of renal function in a patient with multiple myeloma associated with amyloid and light chain depositions. Clin Exp Nephrol. 2009;13:671\u20136.","journal-title":"Clin Exp Nephrol"},{"key":"3207_CR8","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1074\/mcp.M500061-MCP200","volume":"4","author":"Y Ishihama","year":"2005","unstructured":"Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics. 2005;4:1265\u201372. https:\/\/doi.org\/10.1074\/mcp.M500061-MCP200.","journal-title":"Mol Cell Proteomics"},{"key":"3207_CR9","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538\u201348. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5.","journal-title":"Lancet Oncol"},{"key":"3207_CR10","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1182\/blood-2014-04-570010","volume":"124","author":"G Palladini","year":"2014","unstructured":"Palladini G, Hegenbart U, Milani P, Kimmich C, Foli A, Ho AD, et al. A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis. Blood. 2014;124:2325\u201332.","journal-title":"Blood"},{"key":"3207_CR11","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17:e328\u201346. https:\/\/doi.org\/10.1016\/S1470-2045(16)30206-6.","journal-title":"Lancet Oncol"},{"issue":"5","key":"3207_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0046-8177(85)80086-1","volume":"16","author":"P Bruneval","year":"1985","unstructured":"Bruneval P, Foidart JM, Nochy D, Camilleri JP, Bariety J. Glomerular Matrix Proteins in Nodular Glomerulosclerosis in Association with Light Chain Deposition Disease and Diabetes Mellitus. Hum Pathol. 1985;16(5):477\u201384.","journal-title":"Hum Pathol"},{"key":"3207_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2169\/internalmedicine.56.7275","volume":"56","author":"T Kasagi","year":"2017","unstructured":"Kasagi T, Nobata H, Suzuki K, Miura N, Banno S, Takami A, et al. Light chain deposition disease diagnosed with laser micro-dissection, liquid chromatography, and tandem mass spectrometry of nodular glomerular lesions. Intern Med. 2017;56:61\u20136.","journal-title":"Intern Med"},{"key":"3207_CR14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1053\/j.ajkd.2010.06.018","volume":"56","author":"Q Qian","year":"2010","unstructured":"Qian Q, Leung N, Theis JD, Dogan A, Sethi S. Coexistence of myeloma cast nephropathy, light chain deposition disease, and nonamyloid fibrils in a patient with multiple myeloma. Am J Kidney Dis. 2010;56:971\u20136. https:\/\/doi.org\/10.1053\/j.ajkd.2010.06.018.","journal-title":"Am J Kidney Dis"},{"key":"3207_CR15","first-page":"485","volume":"10","author":"EA Turbat-Herrera","year":"1997","unstructured":"Turbat-Herrera EA, Isaac J, Sanders PW, Truong LD, Herrera GA. Integrated expression of glomerular extracellular matrix proteins and \u03b21 integrins in monoclonal light chain-related renal diseases. Mod Pathol. 1997;10:485\u201395.","journal-title":"Mod Pathol"},{"key":"3207_CR16","first-page":"375","volume":"147","author":"L Zhu","year":"1995","unstructured":"Zhu L, Herrera GA, Murphy-Ullrich JE, Huang ZQ, Sanders PW. Pathogenesis of glomerulosclerosis in light chain deposition disease: Role for transforming growth factor-\u03b2. Am J Pathol. 1995;147:375\u201385.","journal-title":"Am J Pathol"},{"key":"3207_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/ki.2012.414","volume":"83","author":"SH Nasr","year":"2013","unstructured":"Nasr SH, Said SM, Valeri AM, Sethi S, Fidler ME, Cornell LD, et al. The diagnosis and characteristics of renal heavy-chain and heavy\/light-chain amyloidosis and their comparison with renal light-chain amyloidosis. Kidney Int. 2013;83:463\u201370. https:\/\/doi.org\/10.1038\/ki.2012.414.","journal-title":"Kidney Int"},{"key":"3207_CR18","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/ndt\/gfv018","volume":"30","author":"S Safadi","year":"2015","unstructured":"Safadi S, Saad A, Quint PS, Sethi S, Leung N, Kurtin P, et al. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis. Nephrol Dial Transplant. 2015;30:1151\u20135.","journal-title":"Nephrol Dial Transplant"},{"key":"3207_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ki.2012.433","volume":"83","author":"MM Picken","year":"2013","unstructured":"Picken MM. Non-light-chain immunoglobulin amyloidosis\u202f: time to expand or refine the spectrum to include light+heavy chain amyloidosis\u202f? Kidney Int. 2013;83:353\u20136. https:\/\/doi.org\/10.1038\/ki.2012.433.","journal-title":"Kidney Int"},{"key":"3207_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1182\/blood-2016-10-743997","volume":"129","author":"TV Kourelis","year":"2017","unstructured":"Kourelis TV, Dasari S, Theis JD, Ramirez-alvarado M, Kurtin PJ, Gertz MA, et al. Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry. Blood. 2017;129:299\u2013306.","journal-title":"Blood"},{"key":"3207_CR21","doi-asserted-by":"publisher","first-page":"850","DOI":"10.5858\/2007-131-850-TBOSAT","volume":"131","author":"MMHG Picken","year":"2007","unstructured":"Picken MMHG. The burden of \u201c\u2018sticky\u2019\u201d amyloid: Typing challenges. Arch Pathol Lab Med. 2007;131:850\u20131.","journal-title":"Arch Pathol Lab Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03207-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03207-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03207-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T19:02:37Z","timestamp":1687806157000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03207-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3207"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03207-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2429335\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"assertion":[{"value":"30 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was exempted from requiring ethics approval from the research ethics committee of Fukui University Hospital as this case report is based on an already described treatment and analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and the accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}